[Therapeutic strategies of mildly malignant non-Hodgkin's lymphoma]

Internist (Berl). 1993 Feb;34(2):132-8.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bone Marrow Transplantation
  • Combined Modality Therapy
  • Humans
  • Interferon-alpha / therapeutic use
  • Interleukin-2 / therapeutic use
  • Lymphatic Irradiation
  • Lymphoma, Non-Hodgkin / mortality
  • Lymphoma, Non-Hodgkin / pathology
  • Lymphoma, Non-Hodgkin / therapy*
  • Neoplasm Staging
  • Purines / therapeutic use
  • Survival Rate

Substances

  • Antibodies, Monoclonal
  • Interferon-alpha
  • Interleukin-2
  • Purines